US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 2.650
  • +0.080+3.11%
Close Nov 29 13:00 ET
  • 2.700
  • +0.050+1.89%
Post 17:01 ET
149.95MMarket Cap-1992P/E (TTM)

About Black Diamond Therapeutics Company

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Company Profile

SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees54
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848
Websitehttp://www.blackdiamondtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark A. Velleca, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 2.95M
  • Erika Jones
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Melanie Morrison
  • Chief Development Officer
  • --
  • Elizabeth Buck, PhD
  • Chief Scientific Officer
  • --
  • Sergey Yurasov, M.D.,Pd.D
  • Chief Medical Officer
  • 1.23M
  • Brent Hatzis-Schoch, Esq.
  • Chief Operating Officer and General Counsel
  • --
  • Elizabeth L. Montgomery
  • Chief People Officer
  • --
  • Shannon Campbell, PhD
  • Independent Director
  • --
  • Dr. Samarth Kulkarni, PhD
  • Lead Independent Director
  • 59.35K
  • Dr. Kapil Dhingra, M.B.B.S.
  • Independent Director
  • 109.35K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 68.14K
  • Dr. Prakash Raman, PhD
  • Independent Director
  • --
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 75.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data